Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-29

Clinical Trial Update: Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing the efficacy, tolerability, and safety of temsirolimus in women with platinum-refractory ovarian cancer or advanced endometrial c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Temsirolimus (temsirolimus)

Snippet

Sponsor: AGO Study Group | Conditions: Genital Diseases, Female, Ovarian Diseases | Phase 2 | Status: COMPLETED